COVID-19: Customer Information

Bruker Partners with Customers to Support major new Frontline Response to Combat the COVID-19 Threat

News related to covid

sars_covid_particles

Bruker Atomic Force Microscopy Solutions Enable Rapid Imaging of Native Infectious and Inactivated SARS-CoV-2 Viral Particles

The global research effort surrounding the novel coronavirus (SARS-CoV-2) responsible for Coronavirus Disease 2019 (COVID-19) has progressed at an unprecedented rate. Given that the virus is classified as a hazard group 3 pathogen, however, only laboratories certified as level 3 biosafety (BSL3) facilities are able to study SARS-CoV-2 in its active state.

Image-Bruker-NMRMS-PACS-NMRLab

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS)

Canopy Biosciences Develops Spatial Proteomics Assay for COVID-19

Canopy Biosciences, a Bruker Company, today announced the successful development of a new assay for examining immune response to COVID-19. The assay uses high-plex spatial proteomics and is performed on Canopy’s ZellScannerONE precise spatial phenotyping instrument.

Bruker-ANPC-COVID-19-2

Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat

Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat.

The Combat Against COVID-19: A Global Network Using NMR Technology

The Combat Against COVID-19: A Global Network Using NMR Technology

Bruker is proud to partner with Dr. Harald Schwalbe of the Goethe University in Frankfurt on using NMR to combat COVID-19.

Bruker MicroCT Systems Supporting Quality Control for Refurbished FFP Masks

As companies and organizations across the world look for ways in which they can play their part, either alone or as part of a collaboration, in the effort to tackle the coronavirus pandemic, Bruker is extremely proud that its instruments are being used to ensure quality levels of reprocessed filtering face pieces (FFP) commonly known as facemasks.

pneumonia_banner

Plasma Metabolomics in H1N1 Influenza Pneumonia Diagnosis

Biomarkers may enable early diagnosis and prognosis, as well as help determine response to treatment. One approach for identifying disease biomarkers is metabolomic profiling.

csr-banner-chinese

The Role of Metabolomics in Understanding Traditional Chinese Medicines

Pneumonia is the world's leading cause of death in young children and elderly people. It is an infection that inflames the air sacs in one or both lungs, filling the air sacs with fluid and causing a cough, fever, chills, and breathing difficulties.

Webinars related to covid

NMR International COVID-19 Research Network at Work

NMR | COVID-19 | Research

In the current worldwide COVID-19 pandemic situation, fast developments not only in vaccines are needed, but also in analytical techniques to detect the infection, predict outcomes during hospitalization and more and more important towards Long COVID.

Drugs that are currently being used to treat COVID-19: remdesivir, chloroquine and the combination of lopinavir/ritonavir.

Treatments of COVID-19: Old Drugs, New Tricks

COVID-19 is a global pandemic caused by the SARS-CoV-2 virus. There is a huge worldwide effort underway to discover vaccines and new drugs

Understanding the structure of the SARS-CoV-2 virus through collaboration in NMR analysis holds the key to finding a treatment.

Collaboration in Science Like in The COVID-19 Pandemic a model for the future

Understanding the structure of the SARS-CoV-2 virus through collaboration in NMR analysis holds the key to finding a treatment.